Wire
Guardian Pharmacy's Site Tour Reinforces Confidence in Prospects, BofA Says
Guardian Pharmacy Services' (GRDN) pharmacy site tour reinforces confidence in the company's long-term market share gains, BofA Securities said in a note Wednesday."We come away from the tour incrementally positive that Guardian has the right employees, culture, and strategy to continue to grow its market share over the next decade," the report said.BofA analysts increased their target multiple to reflect incrementalconfidence on longer-term share gains. BofA kept its buy rating while raising its price target to $47 from $42.Price: $43.08, Change: $+0.66, Percent Change: +1.56%
$GRDN
